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Background
Anthracycline-associated cardiomyopathy is a progres-
sive, dose-dependent complication of Anthracycline che-
motherapy. The period between Anthracycline therapy
and onset of overt heart failure is often years, even dec-
ades, and as such Anthracyclines appear to initiate a
myocardial injury that remains clinically silent for a sub-
stantial period of time. Left ventricular (LV) ejection
fraction (EF) is often preserved during this latent period.
A more sensitive marker of Anthracycline-associated
myocardial injury would allow earlier diagnosis, hence
potentially earlier initiation of cardioprotective therapy,
and better prognostication.
We assessed the relationship between cumulative
Anthracycline dose and myocardial function (global and
regional) and myocardial fibrosis (focal and diffuse) in
patients who had previously received Anthracycline che-
motherapy for acute myeloid leukaemia (AML) with
normal or near normal LV EF.
Methods
15 patients with a prior history of AML underwent 1.5T
CMR (Avanto, Siemens). LV volumetric analysis was
performed on SSFP images. Mitral inflow was assessed
using phase-contrast velocity mapping. Spatial modula-
tion of magnetization was performed on a mid-ventricu-
lar short-axis slice in order to assess peak systolic
circumferential strain (εcc). T1 mapping was performed
pre- and 10-minutes post 0.15mmol/kg gadolinium-
DTPA using a modified look locker inversion recovery
sequence. ΔR1 ratio [(1/T1myocardium post-contrast) -
(1/T1myocardium pre-contrast)] / [(1/T1blood post-
contrast) - (1/T1blood pre-contrast)] was used as a mar-
ker of diffuse myocardial fibrosis. Late gadolinium
enhancement (LGE) images were acquired immediately
after post-contrast T1 mapping.
Results
8 patients were male, mean age 49±17 years. Mean time
since AML diagnosis 7±4 years. Mean cumulative
Anthracycline dose 200±82mg/m2 (range 75-362). Mean
body surface area-indexed end-diastolic volume (EDV)
was 71±10mls/m2, mean indexed end-systolic volume
(ESV) was 30±5mls/m2 and mean EF was 58±6% (range
51-70%).
There was a significant correlation between cumula-
tive Anthracycline dose and EDV (correlation coefficient
0.43, p=0.03) and ESV (0.43, p=0.03), but no correlation
with EF. There were significant correlations between age
and ΔR1 ratio (-0.57, p=0.04), age and εcc (0.59, p=0.02)
and age and E/A ratio (-0.43, p=0.02). There were also
significant correlations between ΔR1 ratio and E/A ratio
(0.58, p=0.003), ΔR1 ratio and indexed EDV (0.44,
p=0.02) and ΔR1 ratio and indexed ESV (0.41, p=0.04).
However, there were no significant correlations between
total Anthracycline dose and ΔR1 ratio (0.25, p=0.19),
total Anthracycline dose and εcc (0.14, p=0.49) or total
Anthracycline dose and E/A ratio (-0.04, p=0.84). No
patient had focal LGE.
Conclusions
In this small group of patients who received chemother-
apy for AML a mean of 7 years previously, there was no
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peak systolic circumferential strain or a marker of dif-
fuse myocardial fibrosis.
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